‘Sick at the desk’ workforce crisis costs UK economy billions every year Business Britain’s workforce health crisis isn’t happening on sick leave; it’s happening at the desk, as employees are working through illness and stress. Poor workforce health is estimated to cost the UK economy £241bn in lost productivity annually, according to claims in a new report by healthcare insurer Vitality, with mental ill-health being the single largest [...]
The aristocratic landowner taking record rent from ‘cradle-to-grave’ health empire Property One of London’s biggest landowning families raked in record rent from its Marylebone property empire last year, helped by a surge in demand at its ‘cradle-to-grave’ private healthcare district. Howard de Walden Estates, which owns the Harley Street health district and the residential Marylebone Village, grew its rental income from the estate by 9.3 per [...]
London-listed healthcare services firm hit by cyberattack Markets Shares in Craneware tumbled in early trading on Monday as the healthcare services firm revealed it had been hit by a cyberattack. The AIM-listed business said the incident involved “unauthorised access to a subset of its data environment”. Early investigations suggest “a significant volume of file names were viewed and exfiltrated”. Employee data as well [...]
Patent cliff fuels Novartis’ $1.5bn swoop for London biotech July 6, 2026 Swiss pharmaceutical giant Novartis has agreed to buy London-based biotech Myricx Bio for up to $1.5bn (£1.1bn) as global drugmakers continue deploying billions into promising biotech firms ahead of an estimated $450bn wave of patent expiries over the next decade. The deal will see Novartis pay $1.1bn upfront, with a further $400m tied to development [...]
GSK says AI is reshaping drug pipeline as Nuvalent deal hits shares June 9, 2026 GSK has said agentic AI is already affecting every asset in its pipeline, as pharmaceutical firms race to use the technology to cut the cost and risk of developing new medicines. Speaking at London Tech Week in Tuesday, Eyal Itskovits, GSK’s director of AI and machine learning, said that the technology has officially become a [...]
NHS gives Palantir wider access to patient data amid growing backlash May 11, 2026 NHS England has expanded access to sensitive patient data for external contractors working on its controversial Palantir-backed data. The move has sparked concerns over privacy for such sensitive data, and the growing influence of American Big Techs inside the UK’s health service. According to the Financial Times, internal briefing documents show NHS officials approved new [...]
Howard de Walden Estate splashes £50m on Harley Street property deals April 28, 2026 The Howard de Walden Estate has spent £50m on acquisitions in the Harley Street neighbourhood, City AM can reveal, as it tightens its dominance over the capital’s private health hub. The property company has acquired three long leaseholds in Harley Street and Wimpole Street, with a combined 50,000 sq ft footprint, featuring a blend of [...]
Chip makers and defence contractors power profit upgrade for London tech stock Renishaw April 20, 2026 London-listed engineer Renishaw upped its profit guidance on Monday, sending its shares to the top of the FTSE 250, helped by demand from defence contractors and chipmakers. The Gloucestershire-based precision tech firm is known for its precision equipment used in the lithography process of making microprocessors. On Monday, it pointed to “a substantial expansion” of [...]
St John Ambulance receives Health Lottery Foundation grant to extend Young Responders programme April 20, 2026 | Sponsored First aid and healthcare charity to deliver essential first aid initiative targeted at young people across the East Midlands for the first time. Thanks to players of The Health Lottery, St John Ambulance has received a grant of nearly a quarter of a million pounds from the Health Lottery Foundation to expand its Young Responders programme [...]
Exclusive: NHS must keep medicine clawback down or lose investment, says weight-jab boss February 18, 2026 The NHS must keep its medicines clawback tax low and predictable or else risk disrupting the rollout of weight-loss drugs in the UK, Novo Nordisk’s UK chief has said. Sebnem Avsar Tuna, general manager of UK operations for the Ozempic and Wegovy maker, told City AM the Government must keep in place the current ceiling [...]